Sun Pharma Advanced Research Company Limited

Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Advanced Research Centre Limited

Dharmadhikari, Nitin Bhalachandra

Singh, Amarjit

Zala, Yashoraj Rupsinh

Kamlesh Mohanlal Dudhara

Nitin Bhalachandra Dharmadhikari

Vaishali Vijay Dhavse

Yashoraj Rupsinh Zala

Amarjit Singh

Dilip Shanghvi

Bramhanand Hanamannavar

Shirish Kulkarni

Sunil Jaiswal

Krishna Sharma

Prashant Kane

Pratibha Sudhir Pilgaonkar

Kirti Ganorkar

Satish Madhukar Gokhale

Abhishek Jain

Satish C Khanna

Manish Ramdas Bagul

Pankaj Khapra

Nachiket Vilas Gole

Umesh Pai

Shivanand P Puthli

Suma G Menon

Jayant S Karajgi

Ratnesh H Shrivastava

Satyashodhan Patil

Dilip Shantilal Shanghvi

An oral solid dosage form comprising a mixture of compound of formula I and a fusible polymeric carrier; and optionally pharmaceutically acceptable excipients, wherein the mixture is an amorphous dispersion.

Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide

An abuse deterrent oral solid dosage form comprising:

Abuse deterrent oral solid dosage form

An oral solid dosage form comprising a mixture of compound of formula I and a fusible polymeric carrier; and optionally pharmaceutically acceptable excipients, wherein the mixture is an amorphous dispersion. 

An oral, solid dosage form comprising a mixture of compound of formula I and a fusible polymeric carrier; and optionally pharmaceutically acceptable excipients, wherein the mixture is an amorphous dispersion. 

Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N'-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide

An oral drug delivery system comprising a coated tablet having one or more surfaces. The coated tablet further comprises a core and a coating surrounding the core. The core comprises an active ingredient composition comprising at least one active ingredient and a pharmaceutically acceptable excipient and a swellable composition located in an immediate vicinity of one or more preselected surfaces. The coating comprises a defect wherein said defect is not a passageway through the preselected portion of the coating and operable to be reliably removed fully from the one or more of the preselected surfaces of the tablet upon contact with an aqueous environment, but not removed from at least one of the surfaces.

Oral drug delivery system

An oral drug delivery system comprising a coated tablet having one or more surfaces. The coated tablet further comprises a core and a coating surrounding the core. The core comprises an active ingredient composition comprising at least one active ingredient and a pharmaceutically acceptable excipient and a reactive composition located in an immediate vicinity of one or more preselected surfaces. The coating is operable to be reliably removed fully from the one or more of the preselected surfaces of the tablet upon contact with an aqueous environment, but not removed from at least one of the surfaces.

A portable device for cutting a capsule which has been filled with a drug formulation is configured to allow for the accurate alignment of the capsule in the capsule holder and includes a blade shaped to cut the upper portion of the capsule so as to open and dispense the drug formulation without any spillage, and the cut end is disposed capably without falling back in the medication. The device operates accurately with different capsule sizes, even with smaller capsule size when dose content is low, and provides a reliable and precise technique for splitting capsules.

Portable device for cutting a capsule

An abuse deterrent immediate release coated reservoir solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.

Abuse deterrent immediate release coated reservoir solid dosage form

The present invention relates to a pharmaceutical composition comprising fingolimod and a weak acid cation exchange resin in the form of an ion-exchange complex and pharmaceutically acceptable 5 excipients.

Fingolimod containing stable composition

An abuse deterrent immediate release biphasic matrix solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.

Abuse deterrent immediate release biphasic matrix solid dosage form

The present invention discloses a method of treating a disease condition susceptible to baclofen therapy, said method comprising orally administering once-a-day in the evening a controlled release drug delivery system comprising baclofen or its pharmaceutically acceptable salt or its derivatives and pharmaceutically acceptable excipients.

Method of treating a disease condition susceptible to baclofen therapy

The present invention relates to a pharmaceutical composition comprising fingolimod and a weak acid cation exchange resin in the form of an ion-exchange complex and pharmaceutically acceptable excipients.

The present invention relates to an oral controlled release pharmaceutical composition in the form of a unit dosage form comprising:

Pharmaceutical composition

An oral drug delivery system comprising a coated tablet having one or more surfaces. The coated tablet further comprises a core and a coating surrounding the core. The core comprises an active ingredient composition comprising at least one active ingredient and a pharmaceutically acceptable excipient and a composition selected from a swellable composition and a reactive composition located in an immediate vicinity of one or more preselected surfaces. The coating comprising water insoluble polymer(s) and leachable component(s) is operable to be reliably removed fully from the one or more of the preselected surfaces of the tablet upon contact with an aqueous environment, but not removed from at least one of the surfaces.

Growing community of inventors

State of Maharashtra, India

Nitin Bhalachandra Dharmadhikari